A retrospective study analysing serological response and safety of BNT162b2 in haemato-oncological patients
Latest Information Update: 13 Dec 2021
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; Pharmacodynamics
- 13 Dec 2021 New trial record
- 01 Nov 2021 Results published in the British Journal of Haematology